Notably, utilizing DNase I and the GSDMD inhibitor disulfiram was more effective in alleviating AKI than the NLRP3 inhibitor MCC950 in our study, which might be because only a part of the self-DNA was oxidized. The gene discussed is GSDMD; the disease is acute kidney injury.